Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Net Income towards Common Stockholders (2019 - 2025)

Pulmonx has reported Net Income towards Common Stockholders over the past 7 years, most recently at -$14.0 million for Q3 2025.

  • Quarterly Net Income towards Common Stockholders rose 1.38% to -$14.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$43.6 million through Dec 2025, up 22.78% year-over-year, with the annual reading at -$56.4 million for FY2024, 7.31% up from the prior year.
  • Net Income towards Common Stockholders was -$14.0 million for Q3 2025 at Pulmonx, up from -$15.2 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$10.2 million in Q3 2021 and troughed at -$16.2 million in Q2 2023.
  • The 5-year median for Net Income towards Common Stockholders is -$14.2 million (2022), against an average of -$14.1 million.
  • Year-over-year, Net Income towards Common Stockholders crashed 163.76% in 2021 and then grew 13.31% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$13.0 million in 2021, then fell by 9.95% to -$14.3 million in 2022, then grew by 2.65% to -$13.9 million in 2023, then rose by 5.29% to -$13.2 million in 2024, then decreased by 5.94% to -$14.0 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Net Income towards Common Stockholders are -$14.0 million (Q3 2025), -$15.2 million (Q2 2025), and -$14.4 million (Q1 2025).